Dividend Track Records

Becton Dickson (BDX) will increase its dividend by 9.5% to $1.04 quarterly per share in 2024. This is the 53rd year in a row that the medical technology company's dividend has been increased. Its the biggest dividend hike by BDX since 2016.

Cencora Inc (COR) , the former AmerisourceBergen Corporation (ABC), will raise its quarterly dividend by 7.8% to a new record high of 55 cents quarterly. This brings the dividend track record to 20 consecutive years of increases. The dividend yield for COR is 0.88% with this 2024 dividend hike being the biggest since 2020 by the pharmaceutical sourcing and distribution services company.

Novo Nordisk , a leading pharmaceutical company based in Denmark, has delivered some impressive dividend statistics for fiscal years 2022 and 2023. Notably, the company achieved over 25 consecutive years of dividend growth, further bolstered by a recent stock split.

On February 3, 2023, French pharmaceutical company Sanofi , a Dividend Aristocrat , announced its annual dividend increase with a 6.9% hike to €3.56 per share for FY 2022. This is the biggest dividend increase by Sanofi in the last 14 years.

On november 10, 2022, Becton Dickinson and Company (trading symbol BDX) declared a quarterly dividend of $0.91 per share, up 4.6% from the previous quarterly dividend. This will mark the 51st consecutive year of increased dividends by the Dividend Aristocrat .

On October 28, 2022, biopharmaceutical company AbbVie (ticker symbol ABBV) announced a 5% dividend increase beginning with the next dividend payable in February 2023. This will mark the 51st consecutive year of dividend growth by ABBV.

Medtronic has raised its dividend 45 consecutive years. Dividend Aristocrat Medtronic PLC (ticker symbol MDT) has announced a dividend increase of 7.9% to 68 cents per share quarterly. The medical technology company will now have raised its dividend 45 consecutive years.

Dividend Aristocrat Cardinal Health (CAH) will increase its quarterly dividend by 1% to $0.4957 per share in 2022, marking 38 years in a row of increased dividends.

Dividend Aristocrat Johnson & Johnson (JNJ) will increase its quarterly dividend by 6.6 percent to $1.13 per share in the second quarter of 2022. This marks the 60th year of higher dividends by the health care giant.

Bristol-Myers Squibb (BMY) will raise its dividend by 10.2 percent to 54 cents per share quarterly. This comes after a 8.9 percent hike to $0.49 per share announced by BMY in 2021. The pharmaceutical company has now raised its dividend for 14 consecutive years. The next quarterly BMY dividend of 54 cents will be payable on February 1, 2022 to stockholders of record at the close of business on January 7, 2022. A new indicated annual dividend rate of $2.16 per share yields 3.6% at a stock price of $60. Bristol-Myers Squibb now pays an estimated $4.79 billion in dividends to shareholders annually. Dividend growth has been picking up in the last three years, lifting the five year average annualized dividend growth rate to 6.7 percent if we include the 2021 dividend hike just announced. Bristol-Myers Squibb Company is is a global specialty biopharmaceutical company.  Bristol-Myers is developing new medicines in the following core therapeutic areas: oncology with a priority in certain t...

Eli Lilly and Company (LLY) will raise its dividend by 15.3 percent to 98 cents per share. This follows a dividend hike of 14.9 percent to $0.85 per share in the first quarter of 2021. The pharmaceutical company has now raised its dividend for 8 consecutive years. The next LLY dividend is payable March 10, 2022, to shareholders of record as of the close of business on February 15, 2022. The new annual indicated rate to $3.92 per share, yields 1.6% at a stock price of $271.40. Eli Lilly and Company is a manufacturer of human pharmaceutical products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. In the U.S., most of Lilly's pharmaceutical products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Outside the U.S, the company promotes its products to healthcare providers primarily through sales represen...

Dividend Aristocrat Abbott Laboratories (ticker symbol ABT) will raise its quarterly dividend by 4.4 percent to $0.47 per share in 2021. This marks the 50th consecutive year of dividend increases by the healthcare company.

AmerisourceBergen Corporation (ABC) will raise its quarterly dividend by 4.5 percent to 46 cents per share in 2021. The year 2021 marks the company's 17th consecutive year of annual dividend increases. In 2020 ABC hiked its dividend by 10 percent with no dividend hike announced in 2019. The increased ABC dividend of $0.46 per common share is payable November 29, 2021, to stockholders of record at the close of business on November 15, 2021. The new annualized dividend of $1.84 per share yields 1.4% at a stock price of $127.57 for the healthcare services provider. If this new dividend hike is included AmerisourceBergen Corporation will pay an estimated $382 million in dividends to shareholders annually. AmerisourceBergen is a pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium...

Becton Dickinson will raise its quarterly dividend by 4.8% Dividend Aristocrat Becton Dickinson (ticker: BDX) will raise its quarterly dividend by 4.8 percent to $0.87 per share, marking the 50th year in a row of increased dividends by the medical equipment maker.

Dividend Aristocrat AbbVie has raised its dividend 50 years in a row Biopharmaceutical company AbbVie (ticker ABBV) hikes the quarterly dividend by 8.5% to $1.41 per share, marking 50 years in a row of dividend increases by ABBV.